Metastatic Malignant Neoplasm in the Leptomeninges clinical trials in New York
5 active Metastatic Malignant Neoplasm in the Leptomeninges trials with a site in New York. Describe your situation to see which ones look like a fit.
- A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
- Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
- Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
- Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Concurrent Azeliragon With Craniospinal Irradiation
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
← All Metastatic Malignant Neoplasm in the Leptomeninges trials